Results 71 to 80 of about 8,186 (203)

FGFR1 Inhibition by Pemigatinib Enhances Radiosensitivity in Glioblastoma Stem Cells Through S100A4 Downregulation

open access: yesCells
Glioblastoma (GBM) is an aggressive and highly heterogeneous tumor that frequently recurs despite surgery followed by radio-chemotherapy and, more recently, TTFields.
Valérie Gouazé-Andersson   +5 more
doaj   +1 more source

A double-edged sword: unusual multiple severe infections with pralsetinib: a case report and literature review

open access: yesFrontiers in Medicine
Selective rearranged during transfection (RET) tyrosine kinase inhibitor, pralsetinib, demonstrated clinical efficacy and was well tolerated in lung and thyroid cancers with RET gene mutations or fusions in clinical trials.
François Poumeaud   +11 more
doaj   +1 more source

Primary urethral cancer: Treatment patterns, responses and survival in localized, advanced and metastatic patients

open access: yesBJUI Compass
Introduction Primary urethral cancer (PUC) is rare, and limited data exist on optimal treatment and survival, particularly in metastatic cases. The objective of this study was to describe treatment patterns, responses and survival in a contemporary ...
Ilfad Blazevic   +17 more
doaj   +1 more source

Home - About - Disclaimer - Privacy